NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $266,000 | -92.6% | 21,915 | -79.1% | 0.00% | -93.8% |
Q4 2021 | $3,578,000 | -41.3% | 104,855 | -17.0% | 0.02% | -46.7% |
Q3 2021 | $6,093,000 | +3.5% | 126,305 | -3.1% | 0.03% | +3.4% |
Q2 2021 | $5,886,000 | -15.6% | 130,315 | -9.9% | 0.03% | -21.6% |
Q1 2021 | $6,974,000 | -19.7% | 144,605 | -10.3% | 0.04% | -24.5% |
Q4 2020 | $8,680,000 | +44.0% | 161,215 | -1.3% | 0.05% | +28.9% |
Q3 2020 | $6,027,000 | +14.7% | 163,390 | -3.6% | 0.04% | +5.6% |
Q2 2020 | $5,253,000 | +19.1% | 169,570 | +6.2% | 0.04% | -5.3% |
Q1 2020 | $4,409,000 | -11.4% | 159,690 | -6.1% | 0.04% | +15.2% |
Q4 2019 | $4,975,000 | +63.4% | 170,070 | +6.8% | 0.03% | +50.0% |
Q3 2019 | $3,044,000 | -13.1% | 159,190 | -0.2% | 0.02% | -15.4% |
Q2 2019 | $3,501,000 | +19.3% | 159,567 | +11.2% | 0.03% | +18.2% |
Q1 2019 | $2,935,000 | – | 143,450 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |